Brief: Pacira Biosciences Q2 Cash & Investments USD 404.2 Million
30/07/2024 21:00
Jul 30 (Reuters) - Pacira Biosciences Q2 adjusted EBITDA USD 62.1 million vs. IBES estimate USD 52.8 million. * Q2 adjusted net income USD 44.2 million vs. IBES estimate USD 35.3 million * Q2 net income USD 18.9 million * Q2 revenue USD 178 million vs. IBES estimate USD 172.5 million
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal